Skip to main content
. 2018 Jul 20;9(56):30837–30846. doi: 10.18632/oncotarget.25745

Figure 5.

Figure 5

(A) Evaluation of the CAFs viability under increasing doses of gemcitabine in cells previously treated or non-treated treated with 10 μM of Chloroquine. (B) Proliferation of PCC3 co-cultured with CAFs previously treated or not treated with 10 μM Chloroquine for 48 h. PCCs were added to the upper part of the transwells and were incubated with increasing concentrations of gemcitabine for 24 h. Error bars ± SEM; n = 3 per group. *P<0.05 compared to control. Experiments were repeated at least 2 times.